Development Candidates

Picture3Vernalis has an impressive portfolio of drug candidates in pre-clinical and clinical development. Our extensive clinical expertise, and highly focused business direction should ensure optimal use of resources and balance the risks in our pipeline.

 

  • A broad and maturing pipeline with candidates for a range of conditions
  • Candidates at varying stages of development
  • Healthy mix of partnered and non-partnered programmes

 

For more information visit the Vernalis plc website

 

Latest News

Results Announcement for the year ended 30 June 2017

Vernalis plc (LSE: VER) today announces its audited financial results for the year ended 30 June 2017, following the year-end trading update published on 18 July 2017.

Read more ...

Product Pipeline

For more information on our pipeline, click below to visit Vernalis plc

Commercial Pipeline

Comm-thumbnailExplore the pipeline ...

 

NCE Pipeline

NCE-thumbnailExplore the pipeline ...

 

Contact Vernalis Research

T: (0)1223 895555
F: (0)1223 895556

Contact information
Maps and directions
Contact form

Fact Sheet

For more information on Vernalis, click on the below image to download a copy of our fact sheet

Vernalis Factsheet May 2015 Page 1